Establishment of a human corneal epithelial cell line lacking the functional TACSTD2 gene as an in vitro model for gelatinous drop-like dystrophy

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 8, 2013, Pages 5701-5711

  Kitazawa, Koji ^a   Kawasaki, Satoshi ^a   Shinomiya, Katsuhiko ^a   Aoi, Keita ^a   Matsuda, Akira ^b   Funaki, Toshinari ^b   Yamasaki, Kenta ^c   Nakatsukasa, Mina ^a   Ebihara, Nobuyuki ^b   Murakami, Akira ^b   Hamuro, Junji ^a   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c DOSHISHA UNIVERSITY   (Japan)

Author keywords

Corneal dystrophy; Gelatinous drop like; Immortalized cells

Indexed keywords

BETA GALACTOSIDASE; CLAUDIN 1; CLAUDIN 7; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CELL PROLIFERATION; COLONY FORMING CELL; CORNEA CELL; CORNEA DYSTROPHY; GELATINOUS DROP LIKE CORNEAL DYSTROPHY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KERATOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; TACSTD2 GENE; VIRAL GENE DELIVERY SYSTEM; VISUAL IMPAIRMENT; WESTERN BLOTTING;

CORNEAL DYSTROPHY; GELATINOUS DROP-LIKE; IMMORTALIZED CELLS;

AMYLOIDOSIS, FAMILIAL; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CELL ADHESION MOLECULES; CELL LINE; CELL PROLIFERATION; CORNEAL DYSTROPHIES, HEREDITARY; EPITHELIUM, CORNEAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 84882976490     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11043     Document Type: Article

References (41)

1. Nakaizumi G. A rare case of corneal dystrophy. Acta Soc Ophthalmol Jpn. 1914;18:949-950.
2. Gartry DS, Falcon MG, Cox RW. Primary gelatinous drop-like keratopathy. Br J Ophthalmol. 1989;73:661-664.
3. Mondino BJ, Rabb MF, Sugar J, Sundar Raj CV, Brown SI. Primary familial amyloidosis of the cornea. Am J Ophthalmol. 1981;925:732-736.
4. Weber FL, Babel J. Gelatinous drop-like dystrophy: a form of primary corneal amyloidosis. Arch Ophthalmol. 1980;98:144-148.
5. Fukjiki K, Kanai A, Nakajima A. Gelatinous drop-like corneal dystrophy in Japanese population [abstract]. In: Vogel F, Sperling K, eds. Proceedings of the 7th International Congress of Human Genetics. Berlin, Germany: Springer-Verlag; 1986;248-249.
6. Kawano H, Fujiki K, Kanai A. Prevalence of gelatinous droplike corneal dystrophy in Japan [in Japanese]. Atarashii Ganka. 1992;9:1879-1882.
7. Tsujikawa M, Kurahashi H, Tanaka T, et al. Identification of the gene responsible for gelatinous drop-like corneal dystrophy. Nat Genet. 1999;21:420-423.
8. Tsujikawa M, Kurahashi H, Tanaka T, et al. Homozygosity mapping of a gene responsible for gelatinous drop-like corneal dystrophy to chromosome 1p. Am J Hum Genet. 1998;63:1073-1077.
9. Cortina MS, Porter IW, Sugar J, de la Cruz J. Boston type I keratoprosthesis for visual rehabilitation in a patient with gelatinous drop-like corneal dystrophy. Cornea. 2012;31:844-845.
10. Ito M, Takahashi J, Sakimoto N. Histological study of gelatinous drop-like dystrophy following excimer laser phototherapeutic keratectomy [in Japanese]. Nippon Ganka Gakkai Zasshi. 2000;104:44-50.
11. Uhlig CE, Groppe M, Busse H, Saeger W. Morphological and histopathological changes in gelatinous drop-like corneal dystrophy during a 15-year follow-up. Acta Ophthalmol. 2010;88:e273-e274. Available at: http://onlinelibrary.wiley. com/doi/10.1111/j.1755-3768.2009.01708.x/pdf. Accessed August 8, 2013.
12. Nagataki S, Tanishima T, Sakimoto T. A case of primary gelatinous drop-like corneal dystrophy. Jpn J Ophthalmol. 1972;16:107-116.
13. Ohzono S, Ogawa K, Kinoshita S, Moriyama H, Manabe R. Recurrence of corneal dystrophy following keratoplasty [in Japanese]. Rinsho Ganka. 1984;38:747-749.
14. Shinozaki K, Yoshino K, Yamagami H, Takamura E. Histochemical examination of recurrent cornea gelatinous drop-like dystrophy [abstract]. Invest Ophthalmol Vis Sci Suppl. 1996;37:S1020.
15. Wang J, Zhang K, Grabowska D, et al. Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma. Mol Cancer Res. 2011;9:1686-1695.
16. Alberti S, Miotti S, Stella M, et al. Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2. Hybridoma. 1992;11:539-545.
17. Ripani E, Sacchetti A, Corda D, Alberti S. Human Trop-2 is a tumor-associated calcium signal transducer. Int J Cancer. 1998;76:671-676.
18. Nakatsukasa M, Kawasaki S, Yamasaki K, et al. Tumorassociated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. Am J Pathol. 2010;177:1344-1355.
19. Fradet Y, Cordon-Cardo C, Thomson T, et al. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984;81:224-228.
20. Weiss JS, Moller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. Cornea. 2008;27(suppl 2):S1-S83.
21. Kawasaki S, Kinoshita S. Clinical and basic aspects of gelatinous drop-like corneal dystrophy. Dev Ophthalmol. 2011;48:97-115.
22. Yamasaki K, Kawasaki S, Young RD, et al. Genomic aberrations and cellular heterogeneity in SV40-immortalized human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2009;50:604-613.
23. Majo F, Rochat A, Nicolas M, Jaoude GA, Barrandon Y. Oligopotent stem cells are distributed throughout the mammalian ocular surface. Nature. 2008;456:250-254.
24. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
25. Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551-555.
26. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell. 1997;886:875-884.
27. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science. 1995;269:1236-1241.
28. Scherer WF, Syverton JT, Gey GO. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953;97:695-710.
29. Araki-Sasaki K, Ohashi Y, Sasabe T, et al. An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci. 1995;36:614-621.
30. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965;37:614-636.
31. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol. 1989;9:3088-3092.
32. Shay JW, Wright WE, Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta. 1991;1072:1-7.
33. Shirodkar S, Ewen M, DeCaprio JA, et al. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell. 1992;68:157-166.
34. Bryan TM, Reddel RR. SV40-induced immortalization of human cells. Crit Rev Oncog. 1994;5:331-357.
35. Wilson SE, Weng J, Blair S, He YG, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci. 1995;36:32-40.
36. Weinrich SL, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet. 1997;17:498-502.
37. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349-352.
38. Offord EA, Sharif NA, Mace K, et al. Immortalized human corneal epithelial cells for ocular toxicity and inflammation studies. Invest Ophthalmol Vis Sci. 1999;40:1091-1101.
39. Guimaraes DP, Hainaut P. TP53: a key gene in human cancer. Biochimie. 2002;84:83-93.
40. Renaud S, Loukinov D, Abdullaev Z, et al. Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res. 2007;35:1245-1256.
41. Wang J, Day R, Dong Y, Weintraub SJ, Michel L. Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther. 2008;7:280-285.